Effectiveness and Safety of DOACs vs. VKAs in AF Patients With Cancer: Evidence From Randomized Clinical Trials and Observational Studies

Background: The use of direct oral anticoagulants (DOACs) is recommended as the preferred treatment drug in patients with nonvalvular atrial fibrillation (AF). However, the effectiveness and safety of DOACs compared with vitamin K antagonists (VKAs) in patients with cancer and AF are still controver...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Fuwei, Xu, Zixuan, Luo, Jun, Yu, Peng, Ma, Jianyong, Yuan, Ping, Zhu, Wengen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Cardiovascular Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8602680/
https://www.ncbi.nlm.nih.gov/pubmed/34805320
http://dx.doi.org/10.3389/fcvm.2021.766377

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8602680/
https://www.ncbi.nlm.nih.gov/pubmed/34805320
http://dx.doi.org/10.3389/fcvm.2021.766377

Ejemplares similares